Abstract:Display Selectivity for ~3 over oclP2Y2 GABA Receptors OMohammad Sayed Alam. Fumiyo Ozoe, Jia Huang, Fumio Matsumura*, and Yoshihisa Ozoe (Dept. Life Sci. Biotechnol., Fac. Life Environ. Sci., Shimane Univ., *Dept. Environ. Toxicol., Univ. Calif., Davis, USA) Ilrtroductiozs. Ionotropic Y-aminobutyric acid (GABA) receptors are widely distributed in the nerve tissues to mediate fast inhibitory neurotransmission, and the GABA receptors of insects are important targets for insect control chemicals. We have reported the synthesis and structure-activity relationships (SARs) of 4or 5-substituted 1-phenyl-1H-1,2,3-triazoles as insecticidal, noncompetitive antagonistsl). In the present study, we further synthesized 4,5-disubstituted phenyltrlazoles and examined the potencies of both monoand disubstituted phenyltriazoles in human P3 and oelP2Y2 GABA receptors. The hcmomeric ~3 receptor was used as an insect GABA receptor model, as the P3 subunit has high sequence similarity to the housefly GABA receptor subunit MdRdl in the putative antagonist-binding site, and the heteromeric ccl~2Y2 GABA receptor is the most abundant subtype in vertebrate brain. We discuss the selectivity and SARS of 1phenyl-1H-1,2,3-triazoles in P3 and ocl ~2Y2 GABA receptors. Materials ~~x~d MethodS. 4,5-Disubstituted 1-phenyl-lH-1,2,3-triazoles were mainly synthesized by the I ,3-dipolar cycloaddition between an azide and an appropriate alkyne. A total of 5 1 compounds, including monosubstituted analogues, were examined for their ability to inhibit the specific binding of [3H]4'-ethynyl-4-n-propylbicycloorthobenzoate (EBOB), a noncompetitive antagonist, to human ~3 and ocl~2y2 GABA receptors. The P3 and oclP2Y2 receptors were stably expressed in S2 and HEK-293 cells, respectively. Three-dimensional SAR analysis and homology modeling studies were performed using SYBYL ver. 7. I and MOE ver. 2006.08, respectively. ResultS and Discussion. 1-(2,6-Dichlor0-4-trifluoromethylphenyl)-1H-1,2,3-triazoles containing an n-propyl group at the 4-position and a chloromethyl, a hydroxymethyl, or a methyl group at the 5-position showed the highest level of affimity for both ~3 and ccl ~2y2 receptors. Most ofthe tested compounds showed higher affmity for the ~3 receptor than for the ocl~2Y2 receptor. Among 4,5disubstituted anlogues, the 4-n-propyl-5-ethyl analogue exhibited the highest (>1133-fold) selectivity for the ~3 receptor versus the o~lP2Y2 receptor, followed by the 4-n-propyl-5-methyl analogue of 1-(2,6-dibromo-4-trifluoromethylphenyl)-lH-1,2,3-triazole, which showed >671-fold selectivity. The combination of 2,6-dichloro and 4-trifluoromethyl substitutions on the phenyl group was also found to be important to exhibit high affinity for both ~3 and (xl~2Y2 receptors. Thus, an n-propyl at the 4-position and a chloromethyl group at the 5-position are optimized substituents as reg'arding high potency in the ~3 receptor (Ki = 660 pM), but in terms of selectivity, an ethyl group proved to be better than a chloromethyl group as the 5-substituent. l) Alam et al. : J. Ag7'ic. Food Chem. , 54, 1 361-1 372 (2006)

Dopamine/serotonin receptor ligands. 12(1): SAR studies on hexahydro-dibenz[d,g]azecines lead to 4-chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the first picomolar D5-selective dopamine-receptor antagonist

Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands

Synthesis, Preliminary Pharmacological Evaluation and Receptor Docking Studies of 10-Amino-3-methoxy-6,8,12,12a-tetrahydro-5h-thiazolo[4',5':4,5]Pyrido[2,1-a]isoquinolin-2-ols As Novel Dopamine D1 Receptor Inhibitors

Synthesis, 3D-QSAR, and Docking Studies of 1-Phenyl-1h-1,2,3-triazoles As Selective Antagonists for Β3 over Α1β2γ2 GABA Receptors

Synthesis of 6-Substituted 1-Phenylbenzazepines and Their Dopamine D1 Receptor Activities

Synthesis And Characterization Of 5-Hydroxy-2-(2-Phenylethyl)Chromone (5-Hpec) And Its Analogues As Non-Nitrogenous 5-Ht2b Ligands

Synthesis of Dopamine Transporter Selective 3-Diarylmethoxymethyl-8-arylalkyl-8-azabicyclo[3.2.1]octane Derivatives.

Structural Manipulation on the Catecholic Fragment of Dopamine D1 Receptor Agonist 1-Phenyl-n-methyl-benzazepines

Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands

Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: Effect on affinity and selectivity for dopamine D3 receptor

Chemistry And Pharmacological Characterization Of Novel Nitrogen Analogues Of Amop-H-Oh (Sazetidine-A, 6[5-(Azetidin-2-Ylmethoxy)Pyridin-3-Yl]Hex-5-Yn-L-Ol) As Alpha 4 Beta 2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists

B 31 O Structure-Activity Relatiouships of 1-PheHryil-1 H-1 , 2 , 3-triazole Antagonists That Display Selectivity for ~ 3 over oclP 2 Y 2 GABA Receptors OMohammad

Design, Synthesis and Evaluation of Benzo[a]thieno[3,2-G]quinolizines As Novel L-Spd Derivatives Possessing Dopamine D1, D2 and Serotonin 5-HT1A Multiple Action Profiles.

Discovery of Novel Potent and Selective Ligands for 5-HT2A Receptor with Quinazoline Scaffold

‘Click’ D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity

Further Studies on Conformationally Constrained Tricyclic Tropane Analogues and Their Uptake Inhibition at Monoamine Transporter Sites: Synthesis of (Z)-9-(substituted Arylmethylene)-7-azatricyclo[4.3.1.03,7]decanes As a Novel Class of Serotonin Transporter Inhibitors

Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors

Synthesis and Nicotinic Acetylcholine Receptor Binding Affinities of 2- and 3-Isoxazolyl-8-azabicyclo[3.2.1]octanes.

Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays

Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.